...: Immunohistochemistry results revealed that the expression of SIRT1 was upregulated with progression from CIN II–III to CC, but was not expressed in normal cervical tissues and CIN I. There was a positive correlation between SIRT1 expression and HPV16 E7 expression in CC tissues, and silencing of HPV16 E7 downregulated...

... pregnancy. Methods/Results: The expression of FAP was analyzed by immunohistochemistry in frozen sections of decidual tissue from early pregnancy (gestational weeks: 6–12). All tissue samples clearly displayed a strong expression of FAP on the surface of stromal fibroblasts. Additionally, the percentage...

...Xiao-fei Sun; Shu-yan Dai Objectives: To explore the expression of Galectin-1 and -9 and clinicopathological features in endometrial carcinoma (EC). Methods: Normal endometrium (NE), atypical endometrial hyperplasia (AH), and endometrial cancer were collected, and immunohistochemistry was used...

...) in the stromal microenvironment of benign and malignant ovarian epithelial neoplasms, and to relate their tissue expression with prognostic factors in ovarian cancer. Methods: α-SMA and FAP were evaluated by immunohistochemistry in malignant ( n = 28) and benign ( n = 28) ovarian neoplasms. Fisher’s exact test...

... cytoplasm, leading to scalloped configuration [ 3 ]. Immunohistochemistry is extremely helpful in diagnosis and the differential procedures in this rare entity [ 17 ]. Negativity for WT-1 (Wilms tumour factor) may be helpful in differentiation between USCC and ovarian cancer [ 13 ]. The strong, diffuse...

... was histopathological diagnosis of ovarian epithelial neoplasia. Exclusion criteria were secondary malignant ovarian neoplasia and preoperative treatment. Serum and tissue levels of GDF-15 were assessed by enzyme-linked immunosorbent assay and immunohistochemistry, respectively. Chi-square test and unpaired t test were...

... endometrial sarcoma Target therapy Immunohistochemistry Table 3 indicates the differences in survival outcome by treatment type and expression of therapeutic targets in the current study patients with UES. The immunoreactivity of each biomarker was different. In some cases, there was almost...

... Prognosis Immunohistochemistry Based on patients' clinical and pathological characteristics, the results of immunohistochemical staining for identification of VM and CD133 expression were organized and summarized in table 2 . Both VM formation and CD133 expression were associated with tumor...

.../l), and culdocentesis yielded 4 ml pale bloody fluid. Laparoscopy  Ectopic pregnancy Pregnancy outcome Sclerosing stromal tumor of the ovary Immunohistochemistry An SSTO is a rare tumor, and little is known about its tissue origin, etiology, and pathogenesis. Sex cord stromal tumors...

... methyltransferases Dysmenorrhea, severity Epigenetics Menorrhagia Immunohistochemistry Adenomyosis is a common gynecologic disorder with a poorly understood pathogenesis [ 1 ]. Presented with a soft and diffusely enlarged uterus, patients with adenomyosis often complain of menorrhagia, dysmenorrhea...

... stained for 3–5 min or until appropriate for microscopic examination with diaminobenzidine and then counterstained with hematoxylin (30 s) and mounted. A negative control was also incorporated using pre-immune IgG instead of the primary antibody. The protocol for immunohistochemistry analysis...

... severe preeclampsia (LS-PE; n = 10 per group). Real-time quantitative PCR and immunohistochemistry were conducted to confirm the expression of α 1 -antitrypsin (α 1 -AT) in the decidual tissues of different subjects. ELISA was employed to detect the α 1 -AT content in the peripheral blood of 90 women (n...

... in a university department. Morphometric features of the myometrium were studied in uteri from pre- and postmenopausal women with and without uterine adenomyosis as the sole pathology. Uteri were also divided according to the phase of the cycle and examined using immunohistochemistry and image analysis. Results...

... to in the content or advertisements. Placental proteins Immunohistochemistry Human chorionic gonadotrophin Schwangerschaftsprotein 1 Pregnancy-associated plasma protein A Ectopic pregnancies Gynecol, obstet. Invest. 23: 97-102 (1987) © 1987 S. Karger AG. Basel 0378-7346/87/0232-009752.75/0 Placental...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. CA 125 Adenomyosis Immunohistochemistry Short Communications Gynecol, obstct. Invest. 23: 122-123 (1987) © 1987 S...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Cervix Cancer, cervical Immunohistochemistry Laminin Collagen IV Gynecol, obstet. Invest. 20: 158-166 (1985) © 1985 S. Karger AG. Basel 0378-7346/85/0203-0158S2.75/0 Basement...

... was localized by immunohistochemistry to syncytiotrophoblast, cytotrophoblast, and intermediate trophoblast of placenta. At 23–30 weeks of gestation and at term IR-PGDH was present in syncytiotrophoblast and intermediate trophoblast, but not in cytotrophoblast in placenta. It was absent from amnion...

..., Sweden Key Words. Uterine artery Neutrotransmitters Neuropeptides Immunohistochemistry Contractile effects Abstract. The intrinsic innervation of the human uterine artery was investigated histochemically, and the motor responses to some of the demonstrated peptides and other humoral factors were...

... female Gonadoblastoma Immunohistochemistry Steroidogenesis Gynecol Obstet Invest 1990;30:189-191 © 1990 S. Karger AG, Basel 0378-7346/90/0303-0189S2.75/0 Bilateral Gonadoblastoma Producing Steroid Hormones in a Patient with 45,X/46,XY Gonadal Dysgenesis Yoshihito Fukamatsu, Yoshiharu Tsukahara...

... indicated that type 1 core chains were newly synthesized according to malignant transformations in endometrial tissues and they were partially fucosylated and partially sialylated. Type 1 chain Precursor Immunohistochemistry Endometrium Endometrial carcinoma Blood group antigen Gynecol Obstet...